{{Rsnum
|rsid=179019
|Gene=TLR7
|Chromosome=X
|position=12871850
|Orientation=minus
|GMAF=0.2122
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=TLR7
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 68.3 | 20.6 | 11.1
| HCB | 55.6 | 28.9 | 15.6
| JPT | 70.5 | 25.0 | 4.5
| YRI | 85.5 | 8.1 | 6.5
| ASW | 0.0 | 0.0 | 0.0
| CHB | 55.6 | 28.9 | 15.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 91.9 | 3.4 | 4.7
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21396113
|Title=TLR7 single nucleotide polymorphisms in the 3' untranslated region and intron independently contribute to systemic lupus erythematosus in Japanese women: a case-control association study
|OA=1
}}

{{PMID Auto
|PMID=19505919
|Title=Toll-like receptor signaling pathway variants and prostate cancer mortality.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}